title: Effect of AAP statement regarding postnatal corticosteroids on ongoing and future randomized, controlled trials.
authors.forename: Lex
authors.initials: L
authors.lastname: Doyle
authors.forename: Peter
authors.initials: P
authors.lastname: Davis
authors.forename: Colin
authors.initials: C
authors.lastname: Morley
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D002675:Child, Preschool; D002908:Chronic Disease; D003907:Dexamethasone / Q000009:adverse effects / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008171:Lung Diseases / Q000188:drug therapy* / Q000517:prevention & control; D016134:Organizational Policy; D010372:Pediatrics / Q000592:standards*; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D012955:Societies, Medical / Q000592:standards; D014481:United States
chemical_list: D000305:Adrenal Cortex Hormones; D005938:Glucocorticoids; D003907:Dexamethasone